No Dye – a Cancer Patient's Gray Hair Turned Black After Immunotherapy

The image above was published in July 2017 by the Journal of the American Medical Association and shows a cancer patient whose gray hair unexpectedly turned black while receiving new immunotherapy drugs.
Cancer patients' gray hair, through new immunotherapy drugs they use, can unexpectedly return to its youthful dark color or black. How did this initially surprising phenomenon occur, astonishing even doctors?
Hair loss with chemotherapy is a familiar side effect. Some targeted cancer drugs taken orally as pills were also known to whiten hair and beards (see the figure below). However, immunotherapy drugs used by 14 patients produced different results. Spanish research observed that lung cancer patients' immunotherapy improved hair pigments.
Whitening of hair and beard in a stage 4. kidney cancer patient after using the targeted cancer drug pazopanib (Votrient).
When first encountered at Barcelona Autonomus Univsersitesi, this was considered a possible one-off. However, when other patients' hair similarly darkened during treatment, photographs documenting their pretreatment appearance were reviewed.
Among 52 lung cancer patients receiving new-generation immunotherapies such as Keytruda, Opdivo and Tecentriq, 14 experienced pigment (hair color) changes during treatment. Changes in these 14 were far from a one-off: of these 14 patients, 13 had hair turn entirely dark brown or black, while 1 developed patches of black. Conversely, in another cancer type, malignant melanoma skin cancer , the same drugs caused loss of hair color, which is striking.
These 14 patients with hair changes also responded more positively and had stable cancer, suggesting that hair color change might indicate immunotherapy effectiveness.
Research continues into whether these results are coincidental. Although important, the study does not currently support using immunotherapy to darken hair. The drugs used are cancer treatments and have immunotherapy-specific side effects as well. Whether hair color change can serve as an immunotherapy biomarker will become clear through further studies.
Sources
No dye: Cancer patients' gray hair darkened on immune drugs.
JAMA. 21 July 2017.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.